Pathak Prajwol, Li Ying, Gray Brian Allen, May William Stratford, Markham Merry Jennifer
Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Department of Pathology, University of Florida, Gainesville, FL, USA.
Case Rep Hematol. 2017;2017:7815095. doi: 10.1155/2017/7815095. Epub 2017 Feb 8.
Chronic myeloid leukemia (CML) and mantle cell lymphoma (MCL) are hematologic malignancies that originate from different oligopotent progenitor stem cells, namely, common myeloid and lymphoid progenitor cells, respectively. Although blastic transformation of CML can occur in the lymphoid lineage and CML has been related to non-Hodgkin lymphoma on transformation, to our knowledge, de novo and synchronous occurrence of CML and MCL has not been reported. Herein, we report the first case of synchronous CML and MCL in an otherwise healthy 38-year-old man. Potential etiologies and pathological relationships between the two malignancies are explored, including the possibility that the downstream effects of BCR-ABL may link it to an overexpression of cyclin D1, which is inherent to the etiology of MCL.
慢性粒细胞白血病(CML)和套细胞淋巴瘤(MCL)是血液系统恶性肿瘤,分别起源于不同的寡能祖干细胞,即常见的髓系和淋巴系祖细胞。虽然CML的原始细胞转化可发生在淋巴系,且CML在转化时与非霍奇金淋巴瘤有关,但据我们所知,CML和MCL的新发和同步发生尚未见报道。在此,我们报告首例38岁健康男性同步发生CML和MCL的病例。探讨了这两种恶性肿瘤之间的潜在病因和病理关系,包括BCR-ABL的下游效应可能将其与细胞周期蛋白D1的过表达联系起来的可能性,而细胞周期蛋白D1的过表达是MCL病因所固有的。